High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
British Journal of Dermatology2015Vol. 174(1), pp. 146–151
Citations Over TimeTop 10% of 2015 papers
Abstract
High NLR (≥4) before initiating ipilimumab treatment in patients with metastatic melanoma is an independent prognostic indicator of poor survival.
Related Papers
- → The Predictive Value of Total Neutrophil Count and Neutrophil/ Lymphocyte Ratio in Predicting In-hospital Mortality and Complications after STEMI(2014)84 cited
- → The evaluation of pretreatment neutrophil–lymphocyte ratio and derived neutrophil–lymphocyte ratio in patients with laryngeal neoplasms(2018)33 cited
- → Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s disease(2018)18 cited
- → The Importance of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in ST Elevation Myocardial Infarction(2014)1 cited
- → Total White blood count, absolute neutrophil count and neutrophil lymphocyte ratio and heart failure in patients with STEMI(2022)